BALLESTRI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.851
EU - Europa 1.904
AS - Asia 1.791
SA - Sud America 258
AF - Africa 27
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.819
SG - Singapore 612
GB - Regno Unito 578
CN - Cina 532
PL - Polonia 243
HK - Hong Kong 242
SE - Svezia 231
BR - Brasile 205
IT - Italia 204
DE - Germania 195
VN - Vietnam 143
RU - Federazione Russa 106
UA - Ucraina 94
TR - Turchia 78
FI - Finlandia 69
BG - Bulgaria 45
FR - Francia 42
IN - India 30
JP - Giappone 29
ID - Indonesia 28
LT - Lituania 28
KR - Corea 27
AR - Argentina 26
CA - Canada 19
NL - Olanda 13
BD - Bangladesh 10
CZ - Repubblica Ceca 10
MX - Messico 10
ZA - Sudafrica 10
IE - Irlanda 9
MY - Malesia 9
VE - Venezuela 9
PK - Pakistan 8
BE - Belgio 7
UZ - Uzbekistan 7
AT - Austria 6
AU - Australia 6
EC - Ecuador 6
IQ - Iraq 6
NZ - Nuova Zelanda 6
RO - Romania 6
PH - Filippine 5
CL - Cile 4
EU - Europa 4
SA - Arabia Saudita 4
BO - Bolivia 3
EG - Egitto 3
ES - Italia 3
KE - Kenya 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CO - Colombia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
TJ - Tagikistan 2
TW - Taiwan 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.848
Salva come PNG Salva come JPEG
Città #
Fairfield 759
Ashburn 516
Santa Clara 476
Woodbridge 461
Singapore 389
Houston 359
Southend 338
Seattle 336
Chandler 312
Wilmington 301
Cambridge 246
Warsaw 241
Hong Kong 240
Dearborn 192
Ann Arbor 182
Nyköping 165
Jacksonville 135
London 114
Hefei 107
New York 106
Beijing 103
Chicago 102
Los Angeles 82
Modena 80
Council Bluffs 48
Sofia 45
Eugene 43
Ho Chi Minh City 43
Izmir 43
Princeton 43
San Diego 43
Helsinki 40
Salt Lake City 37
Hanoi 35
Moscow 33
Shanghai 30
Seoul 25
The Dalles 25
Jakarta 23
Munich 23
Buffalo 21
Dallas 21
São Paulo 21
Elk Grove Village 18
Tokyo 18
Redwood City 17
Tampa 17
Frankfurt am Main 15
Columbus 14
Des Moines 14
San Mateo 12
Denver 11
Guangzhou 11
Phoenix 11
Dong Ket 10
Kansas City 10
Rome 10
Bremen 9
Chennai 9
Dublin 9
Kunming 9
Lancaster 9
North Salt Lake 9
Redondo Beach 9
San Francisco 9
Brno 8
Jersey City 8
Padova 8
Atlanta 7
Boardman 7
Brussels 7
Falls Church 7
Haiphong 7
Milan 7
Nanjing 7
Norwalk 7
Poplar 7
Rio de Janeiro 7
Sterling 7
Ankara 6
Auckland 6
Brooklyn 6
Buenos Aires 6
Jinan 6
Johannesburg 6
Naples 6
Nuremberg 6
Orem 6
Stockholm 6
Tashkent 6
Turku 6
Bologna 5
Dulles 5
Florence 5
Fremont 5
Gifu 5
Goiânia 5
Manchester 5
Toronto 5
Augusta 4
Totale 7.461
Salva come PNG Salva come JPEG
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 436
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 396
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 351
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 349
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 338
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 317
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 308
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 307
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 290
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 277
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 271
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 269
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 268
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 260
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 259
Nonalcoholic fatty liver disease and aging: epidemiology to management 256
A critical appraisal of the use of ultrasound in hepatic steatosis 243
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 242
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 237
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 237
Alcohol and Steatosis: The Japanese Paradox 228
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 226
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 221
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 220
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 216
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 213
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 201
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 198
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 197
Nanoparticles: potential toxins for the organism and the kidney ? 181
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 174
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 172
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 172
Gli enzimi epatobiliari nella diagnostica clinica delle Epatopatie. 170
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 168
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 165
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis - Contrast-Enhanced Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma 161
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 153
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 153
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 152
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 125
Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease 85
Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease 67
Totale 9.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021748 0 0 0 0 0 129 82 161 63 135 114 64
2021/2022782 34 95 77 31 17 37 48 29 102 75 172 65
2022/2023827 82 126 62 76 87 116 16 79 96 8 34 45
2023/2024457 15 25 42 24 97 61 21 39 10 4 56 63
2024/20251.754 48 21 36 121 361 252 143 135 178 71 167 221
2025/20262.017 221 108 241 411 652 384 0 0 0 0 0 0
Totale 9.929